moderna

Shares of Moderna (NASDAQ: MRNA) jumped 15% last Thursday after the drugmaker announced solid fourth-quarter financial results. The company revenue for the last quarter increased to $7.2 billion from $571 million compared to the same period in 2020. Meanwhile, the overall sentiment of the stock...

American Biotechnology firm, Moderna (NASDAQ: MRNA) shares closed in positive for the second consecutive day. The $MRNA stock closed more than 6% higher on Wednesday after the early data of its experimental COVID-19 vaccine showed comparable immune response between older and younger volunteers...